Give me some symbols to check out
I just got an etrade account, what should I invest in?
Collapse
X
-
Comment
-
Throw a bit of money on CMKX. They have mineral rights for 1.4 million acres in a diamond rich region of Saskatchewan. The stock was at $0.0002 last week, and it's now at $0.0005. If they find some nice rocks, the PPS will explode to $0.1 - $0.5.Comment
-
Acacia is a good one if you have money you don't want anymore.Comment
-
Originally posted by p1mpdogg
shell oil
thats the kind of gas they used on the stupid cat
Your Paysite Partner
Strength In Numbers!
StickyDollars | RadicalCash | KennysPennies | HomegrownCashComment
-
http://research.businessweek.com/scoreboard.asp
Businessweek doesn't fuck around. It's published straight outta Ca$hville.
Graph paper was the original Photoshop.
R.I.P. C64, Apple //e, Peek & Poke.Comment
-
Is that Ca$hville U.S.A?Originally posted by molly_muddblood
http://research.businessweek.com/scoreboard.asp
Businessweek doesn't fuck around. It's published straight outta Ca$hville.
-GregComment
-
gameznflix
i wouldnt recommend etrade though. i had an account with them when i was in high school. bought some stocks and decided to let them sit. i had about 1500 worth and while i wasnt checking my account they came out with a new rule saying you needed like $4k in your account or you get a $25 service fee per month. i noticed this after a year and they screwed me out of about $300 or so. i bitched and they pretty much told me tough shit.I host with VacaresComment
-
-
etrade sucks cock transfer your money to scottrade asap
7 dollars market orders over 1 dollar. No inactivity fees among a ton of other featuresComment
-
Keep an eye on these two
Absolut Resources They hit pay dirt in Peru. Stock shot up over 150% in one day a few weeks ago. The find is looking comparable to Barrick Golds Alto Chicima discovery in Peru. The stock will start moving again as more drill results are released in the coming months.
BioMS These guys have a great treatment in the pipeline for MS. They received Health Canada approval back in June for Phase 3 trials. They are in advanced discussions with the FDA in the U.S. for orphan drug status. They are more then likely too receive approval sometime in the next 6 months as there is no treatment like their's available and the drug hasn't had any side effects too date in people who have taken it. They are also well on their way to getting a Nasdaq listing which will bring U.S. Bio investors into the shares.
Both stocks will probably float for a bit but they will make you money at their current prices.Comment




Comment